{"id":4701,"date":"2021-04-19T15:39:10","date_gmt":"2021-04-19T22:39:10","guid":{"rendered":"https:\/\/www.iths.org\/participate\/?p=4701"},"modified":"2021-04-19T19:25:42","modified_gmt":"2021-04-20T02:25:42","slug":"skylark-postpartum-depression-study","status":"publish","type":"post","link":"https:\/\/www.iths.org\/participate\/skylark-postpartum-depression-study\/","title":{"rendered":"Skylark Postpartum Depression Study"},"content":{"rendered":"<div class='box summary'><\/div>\n<p>To determine if treatment with SAGE-217 reduces depressive symptoms in women with postpartum depression (PPD) compared to placebo.<br \/>\nTo determine if treatment with SAGE-217 reduces anxiety symptoms compared to placebo.<br \/>\nTo assess self-report of depressive symptoms<br \/>\nTo evaluate the safety and tolerability of SAGE-217<\/p>\n<p>This is a PHASE 3 study.<\/p>\n<p>Duration of participation will be up to 76 days, including screening, treatment period, and follow-up period.<\/p>\n<h3>Participant Eligibility<\/h3>\n<p>Ambulatory females between 18 and 45 years of age, inclusive<br \/>\nParticipant must be in good physical health<br \/>\nCannot be participating in night shift work<br \/>\nParticipant has ceased lactating or agrees not to provide breastmilk to infant(s) from just prior to Day 1 of receiving medication until 7 days after last dose of medication.<br \/>\nCannot be pregnant during study<br \/>\nParticipant is no more than 12 months postpartum<\/p>\n<h3>Contact<\/h3>\n<p>Enroll<br \/>\n(142) 545-3040 x4____<\/p>\n<div class=\"box \"><\/p>\n<h3 class=\"dets\">Additional Study Details<\/h3>\n<p><span class=\"st\"><strong>Full Study Title<\/strong><br \/>\nA Randomized, Double-Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of SAGE-217 i the Treatment of Adults with Severe Postpartum Depression<br \/>\n<\/span><\/p>\n<div class=\"lhalf sid\"><strong>Study ID:<\/strong> 20201036<\/div>\n<div class=\"rhalf ctlink\"><strong>ClinicalTrials.gov Link:<\/strong> <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT02978326\" target=\"_blank\" class=\"link-outbound\" rel=\"noopener noreferrer\">NCT02978326<\/a><\/div>\n<div class=\"clear\"><\/div>\n<div class=\"lhalf start\"><strong>Start Date:<\/strong> 12\/01\/2016<\/div>\n<div class=\"rhalf end\"><strong>End Date:<\/strong> 12\/31\/2021<\/div>\n<div class=\"clear\"><\/div>\n<p><span class=\"pi\"><strong>Investigator(s)<\/strong><br \/>\nArifulla Khan<br \/>\n<\/span><br \/>\n<span class=\"healthy\"><strong>Accepts Healthy Volunteers?<\/strong><br \/>\nNo<\/span><\/p>\n<p><strong class=\"ssites\">Study Site(s)<\/strong> <\/p>\n<div class=\"lhalf site1\">\n<h4>Northwest Clinical Research Center<\/h4>\n<p>1951 152nd PL NE 200<br \/>\nBellevue, Washington 98007<\/p><\/div>\n<div class=\"rhalf site2\">\n<h4><\/h4>\n<\/p><\/div>\n<div class=\"clear\"><\/div>\n<p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>To determine if treatment with SAGE-217 reduces depressive symptoms in women with postpartum depression (PPD) compared to placebo. To determine if treatment with SAGE-217 reduces anxiety symptoms compared to placebo. To assess self-report of depressive symptoms To evaluate the safety and tolerability of SAGE-217 This&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,24],"tags":[1218,1217],"class_list":["post-4701","post","type-post","status-publish","format-standard","hentry","category-mental-health-and-behavior","category-womens-health","tag-baby-blues","tag-postpartum-depression"],"_links":{"self":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts\/4701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/comments?post=4701"}],"version-history":[{"count":1,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts\/4701\/revisions"}],"predecessor-version":[{"id":4702,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts\/4701\/revisions\/4702"}],"wp:attachment":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/media?parent=4701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/categories?post=4701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/tags?post=4701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}